# q01 rev 2 - local removal probe without D01 (platform Doc 4), 2026-10-06

Design evidence, not a blind solve. Fresh blind-solver on packet runs/q01-r2-probe-h8/solver-1:
a byte copy of the rev 2 solver-1 packet minus D01, remaining ids renumbered contiguously
(probe D01 = D02, D02 = D03, D03 = D04, D04 = D05, D05 = D06), neutral run name, bound with
docket_agent.bind_scope. Prompt: root, packet, verbatim rev 2 question, plus a forced best answer.

Raw return as received (probe ids):

answer: Guidance called for Cencora's "Other" group to post a **1% to 4% decline** in fiscal 2026 adjusted operating income. That is about $338M–$348M against the fiscal 2025 actual of $352M. This is the guidance issued November 5, 2025, which is the latest guidance in the packet published before the April 2026 closing. The packet does not fully settle the answer. My forced best answer is "1% to 4% decline", and I put the probability that it is correct at about 0.6.

confidence: medium

path:
1. **Closing date.** D04 (Q3 FY2026 release, filed 2026-08-05):
   - Line 81: "U.S. Consulting Services (which was divested in April 2026)"
   - Line 95: "due to the April 2026 divestiture of U.S. Consulting Services"
   - Footnote at line 269 repeats "which was divested in April 2026."
   - D04 is the only document that dates the closing. D02 never mentions "April."
2. **Which group held the unit.** D05 (Q4 FY2025 release, filed 2025-11-05), line 121: "Beginning in the first quarter of fiscal 2026, the Company's reporting structure will be comprised of U.S. Healthcare Solutions, International Healthcare Solutions, and Other… Other, which is not considered a reportable segment… includes MWI Animal Health, Profarma, U.S. Consulting Services and the other components of PharmaLex." D02 line 86 still lists "U.S. Consulting Services" in Other as of March 31, 2026.
3. **Guidance in effect before the closing.** D05, lines 135–138, adjusted operating income:
   - Total: "8% to 10% growth"
   - "Other(1)|1% to 4% decline|$352M"
   - Arithmetic: 352 × 0.99 = 348.5; 352 × 0.96 = 337.9.
4. **Updates after the closing.**
   - D02 (filed 2026-05-06), line 112: "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'." Line 123: "Other(2)|High-single digit growth|$352M."
   - D04, line 118: "Other(2)|~10% growth|$352M."
   - Both came after April 2026, so neither was the guidance at the closing.
5. **Continuity check.** D02 line 17 says EPS guidance was "raised from the previous range of $17.45 to $17.75." That matches the November range in D05 line 139, so the EPS line was unchanged until May 6.
6. **Timing of the impairment.** D02 shows the U.S. Consulting held-for-sale impairment ($249.5M) only in the six-month column (lines 237 and 260), not in the March quarter. So the unit was classified as held for sale in Q1 FY2026.

minimal_documents: D04 and D05. D02 supports the answer by showing the "High-single digit growth" figure arrived on May 6, after the closing. D01 and D03 contain no "2026" references and are irrelevant.

readings:
- **First guidance after the closing.** If "at the time of the closing" means the first update after it (May 6, 2026), the answer is "High-single digit growth." D02 still listed the unit in Other because its period ended March 31. This reading conflicts with the April closing date.
- **Latest guidance.** The August 5, 2026 figure, "~10% growth," came well after the closing.
- **Company-wide figure.** Total adjusted operating income growth was 8% to 10% (November guidance). That is not the requested group.

gaps:
- **Missing Q1 FY2026 release.** The early-February 2026 release, the last guidance before the April closing, is not in the packet. D02 shows that some guidance lines were revised between November and May outside the packet:
  - Interest expense was "narrowed" to "~$485M." That is incompatible with D05's "$315M to $335M," so a different range must have been issued in between.
  - Share count is "incrementally lower" at "Under 195.5M," versus D05's "~194M."

  So an intermediate update existed. Whether it changed Other's operating income line cannot be determined from the packet.
- **Probability reasoning.** Q1 FY2026 Other operating income fell about 6.1% (D02: (183,050 − 91,633) = 91,417 vs. (190,180 − 92,851) = 97,329). The EPS range was unchanged until May, and D02 attributes the Other change specifically to MWI's May held-for-sale status. Together these make it more likely than not that "1% to 4% decline" was still in effect in April.
- **Lost bold markers.** The "Bolded figures indicate updates" markers in D02 and D04 are lost in both the text/ and docs/ copies. That bolding would have shown which lines changed on May 6.
- **Unread coverage.** These parts were covered only by keyword searches (consulting, divest, April, held for sale, guidance, expectations, outlook, 2026), not read in full:
  - D02 lines 430–454 and 645–675
  - D04 lines 161–259, 275–454 and 650 to end
  - D05 lines 176–677
  - D01 and D03 in their entirety

contaminated: no

Files: `D:\Dev\Docket\tasks\aq-01322\runs\q01-r2-probe-h8\solver-1\text\D05.txt`, `...\text\D02.txt`, `...\text\D04.txt`

Caller note: forced answer "1% to 4% decline" (p 0.6), not the gold: Doc 4 is needed under the
rev 2 wording.
